Whistleblower Law Insights

Maxwell Manor nursing home of Chicago has agreed to settle a False Claims Act suit alleging that they billed the government for inadequate or worthless services. Abuse and neglect was said to be pervasive...

Perini Corporation, a Massachusetts-based construction contractor, will pay the United States $998,500 to resolve claims that the company inflated its request for compensation for delays in construction....

TBC Products, an indirect subsidiary of drug wholesaler McKesson Corp., has agreed to plead guilty to attempting to obstruct a federal audit. It will pay $7.4 million as a fine and civil settlement. Federal...

Diebold has agreed to pay the state of California $2.6 million to settle claims that it falsely certified the security of its electronic voting machines, misleading six counties into buying the machines....

Urologist G. Craig Kiser has agreed to a settlement with the Oregon Attorney General and the U.S. Attorney. Kiser was charged with improperly billing Medicare and Medicaid for drugs received as free samples...

PolyMedica Corp., a medical supply company, has reached a tentative $35 million settlement with the federal government over alleged Medicare fraud. The company was alleged to have shipped diabetes test...

Thomas Armbruster, a West Pasco, Florida obstetrician, will pay $577,000 to settle charges that he billed Medicaid for birthing services that were performed by nurse midwives. In addition to representing...

Custer Battles, a firm with $100 million in Iraqi security contracts, has been charged in a whistleblower lawsuit with repeatedly billing the occupation authorities for nonexistent services or at grossly...

Photon Research Associates and its chief executive have paid $1.9 million to settle charges that the firm inflated labor costs on government contracts. The suit was brought by a whistleblower under the...

Genentech is the latest biotech company to be served with subpoenas relating to drug promotion. It is believed that the investigation concerns off-label marketing of Rituxan, a cancer drug. Doctors may...